Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Agouron Pharmaceuticals, Inc. patentsThe following is a sampling of recent Agouron Pharmaceuticals, Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
July 2011 - Agouron Pharmaceuticals, Inc. patents
20110182884 - P-cadherin antibodies
April 2011 - Agouron Pharmaceuticals, Inc. patents
20110091455 - Antibodies to myostatin
August 2006 - Agouron Pharmaceuticals, Inc. patents
20060189681 - Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
20060178374 - Aminoheteroaryl compounds as protein kinase inhibitors
July 2006 - Agouron Pharmaceuticals, Inc. patents
20060167056 - Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
20060160858 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
20060160863 - Polymorphic and amorphous forms of 2-{3-[(e)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1h-indazol-6-ylamino}-n-(4-hydroxy-but-2-ynyl)benzamide
20060154990 - Use of mek inhibitors in treating abnormal cell growth
June 2006 - Agouron Pharmaceuticals, Inc. patents
20060142312 - C6-aryl and heteroaryl substituted pyrido[2,3-d] pyrimidin-7-ones
20060142345 - 3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
20060128724 - Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
20060122211 - Hiv integrase inhibitors, pharmaceutical compositions and methods for their use
20060122399 - Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
20060116519 - Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
May 2006 - Agouron Pharmaceuticals, Inc. patents
20060111277 - Echinocandin/carbohydrate complexes
20060111322 - Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
20060100170 - Isopycnic pharmaceutical formulation
20060100198 - Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one
20060091067 - Methods for the removal of heavy metals
20060094763 - Polymorphic forms of 6-[2-(methylcarbomoyl) phenyl sulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole
20060094881 - Methods of preparing indazole compounds
April 2006 - Agouron Pharmaceuticals, Inc. patents
20060079548 - Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
20060074073 - Therapeutic combinations comprising poly (adp-ribose) polymerases inhibitor
March 2006 - Agouron Pharmaceuticals, Inc. patents
20060063926 - Method of preparing poly(adp-ribose) polymerases inhibitors
20060052608 - 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
20060046287 - Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
20060046966 - Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
20060046991 - Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
February 2006 - Agouron Pharmaceuticals, Inc. patents
20060035907 - Methods of treating abnormal cell growth using c-met and m-tor inhibitors
20060024288 - Trna synthetase fragments
January 2006 - Agouron Pharmaceuticals, Inc. patents
20060020012 - Pyrazole derivatives
20060014821 - Inhibitors of sars 3c like protease
20060009493 - Indolinone hydrazides as c-met inhibitors
20060009510 - Method of synthesizing indolinone compounds
20060009517 - Tricyclic inhibitors of poly(adp-ribose) polymerases
20060004052 - Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
20060004063 - Inhibitors of hcv ns5b polymerase
December 2005 - Agouron Pharmaceuticals, Inc. patents
20050287325 - Pharmaceutical containers with low adsorption/absorption of active ingredients, and a method of testing materials for adsorption/absorption of active ingredients
20050288353 - Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
20050277661 - Inhibitors of the hiv integrase enzyme
20050277662 - Inhibitors of the hiv integrase enzyme
20050272743 - Prostaglandin derivatives
20050272747 - Preparation of triazoles by organometallic addition to ketones and intermediates therefor
August 2005 - Agouron Pharmaceuticals, Inc. patents
20050182074 - Combination of voriconazole and an antifungal cyp2c19 inhibitor
20050182078 - 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
20050182122 - Method of treating abnormal cell growth using indolinone compounds
20050176701 - Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
20050176773 - Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use
20050176802 - Pyrrole substituted 2-indolinone protein kinase inhibitors
20050171037 - Therapeutic combinations
20050171038 - Therapeutic combinations
20050171357 - Process for preparing indolinone derivatives
July 2005 - Agouron Pharmaceuticals, Inc. patents
20050165040 - Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
20050153903 - Methods of preparing compounds useful as protease inhibitors
20050154056 - Inhibitors of hcv ns5b polymerase
20050148631 - Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
20050148643 - Carbamate compositions and methods fo rmodulating the activity of the chk1 enzyme
June 2005 - Agouron Pharmaceuticals, Inc. patents
20050137214 - 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
20050137263 - N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
20050137395 - Novel quinoline derivatives
20050138675 - Method for determining cardiotoxicity
20050129772 - Compositions comprising an hiv protease inhibitor
20050130940 - Triazole derivatives useful in therapy
20050131011 - Chemical compounds
20050124662 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
20050124673 - Methods of preparing compounds useful as protease inhibitors
20050124683 - Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
20050118255 - Salts and polymorphs of a pyrrole-substituted indolinone compound
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Agouron Pharmaceuticals, Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Agouron Pharmaceuticals, Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
